CCNB2 and breast cancer: Other studies which investigated proliferation-related markers in BC, including CCNB2 and Ki67, demonstrated that high expression of these biomarkers was associated with the features of aggressive tumour behaviour, such as LVI, large tumour size, and shorter survival [26, 67].